4881 FunPep
- 170
- -11-6.08%
FunPep News
The Tokyo Stock Exchange's Gross index rebounded after 4 days, with major stocks rising despite Sanbio being at the limit-down.
Tokyo Stock Exchange Growth Market Index 822.90 +10.71 / Volume of 159.8 million shares / Trading value of 153.4 billion yen Tokyo Stock Exchange Growth Market 250 Index 638.15 +9.47 / Volume of 161 million shares / Trading value of 101.6 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index rebounded for the first time in four days. The number of rising stocks was 330, the number of falling stocks was 216, and the unchanged stocks were 32. On June 19, the US stock market celebrated Juneteenth, which commemorates the emancipation of slaves.
Volume change rate ranking (as of 10 am) - Mitsubishi Motors, Fujita Kan and others ranked.
In the volume change rate ranking, you can understand the interests of market participants such as trends in articles by comparing the average volume of the last 5 days with the volume on the delivery day. ■ Volume change rate top [As of 10:32 on June 19] (comparison of average volume of last 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Stock price change rate ＜9722＞ Fujita Kan 562,000 867,177.4 165.36% 0.102
Part 2 of the stocks that moved the previous day include Ise Chemical Industries, River Eletech, Dai Communications, etc.
Stock Name <Code> 11 Day Closing Price ⇒ Compared to Previous Day Eisai <4523> 6649-223: news of approval recommendation for Donanemab gumi <3903> 331-10: negative view following last weekend's earnings announcement CyberAgent <4751> 930.6-23.7: announcement of free live streaming of UEFA EURO 2024 including other news capcom co., ltd. <9697> 2915-61.5: backlash of stock price increase from the second half of the month rakuten group <
Stocks that moved the day before, part 2: Hitachi, Mitsubishi Electric, Sun Electronics, etc.
Stock Name<Code> 10-day closing price⇒compared to yesterday Money Forward <3994> 5042 -176 Asset Management ONE's shareholding ratio declined. Sansan <4443> 1603 -45 Even among small and medium-sized growth stocks, it stood out with insignificant movements. Gumi <3903> 341 -5 It is negatively viewed due to a significant deficit in the previous period and a decline in dividends. ACCESS <4813> 1384 -151 There is a feeling of completion even for the rebound after the earnings report. Solasta <6197> 461 -14 Nomura
The TOPIX has continued to rise and has remained flat within a narrow range after a rebound.
Tokyo Stock Exchange's Growth Market Index 807.78 +6.27/Volume 142.69 million shares/Trading value 133 billion yen Tokyo Stock Exchange Growth Market 250 Index 625.78 +4.14/Volume 84.77 million shares/Trading value 81.6 billion yen Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index continue to rise. The number of rising stocks is 359, the number of falling stocks is 180, and unchanged stocks are 33. In the US market on the 7th, the Dow Jones Industrial Average was down 87.18 dollars to 38798.99 dollars.
Emerging Markets Digest: Trace OP significantly decreased, while J Frontier sharply increased.
<4881> Fanpeppu 176 +17 sharply rose. Buying is expected for the future progress due to the announcement that FPP004X, an allergy vaccine under development, is targeting the first quarter of the 25th year-end for the start of Phase 1 clinical trials after the end of trading on the 7th. The company has signed an option agreement with Shionogi & Co., Ltd. for FPP004X and has the option to acquire exclusive research and development and commercialization rights for all diseases worldwide.
Fanpep - skyrocketing, announced the start time of the Phase 1 clinical trial of allergy vaccine.
There has been a sudden surge. After the close of trading on the 7th, there was buying interest in anticipation of future progress as they announced their goal of starting phase 1 clinical trials for the developing allergy vaccine, 'FPP004X', in the first quarter of the fiscal year ending December 2025. The same company has signed an option contract for FPP004X with Shionogi & Co., Ltd., and holds the option right to acquire exclusive research and development and commercialization rights for all diseases worldwide.
Non-clinical trial data and expected start time for clinical trials of Fanpep - antibody induced peptide "FPP004X".
On the 7th, Fanpep announced non-clinical trial data and the planned start date of clinical trials for a developing allergy vaccine (antibody-inducing peptide "FPP004X"). FPP004X is expected to induce antibody production against IgE (Immunoglobulin E), which causes an allergic reaction when bound to allergens such as pollen in the body, and have therapeutic effects. The company aims to alleviate symptoms throughout the season by administering the vaccine prior to pollen dispersion, benefiting patients.
Weighed down by sluggishness, falling US stocks and rising long-term US interest rates.
[Emerging markets individual stock strategy] Today's emerging markets are expected to show a sluggish trend. In the US stock market last weekend on the 7th, the Dow Jones average fell for the fourth day, closing at 38,798.99, down 87.18 dollars (-0.22%). The buying expectation that exceeded the expected May employment statistics and prompted early interest rate cuts has receded. On the other hand, the optimistic expectations for the economy have also spread, which has become a supporting factor for stock prices and there have been moments of temporary increase. Today's emerging markets are expected to be dominated by sell offs.
Part 2 of the previous day's moving stocks include Asterisk, Noilimmune, Advantest, etc.
Company name <Code> 7 day closing price ⇒ Compared to the previous day, Okasan Securities Group <8609> 783 -24. The securities sector is the top decliner by global sector. Matsumotokiyoshi Holdings & Company <3088> 2,145 -64. Morgan Stanley MUFG Securities lowered its target stock price. SG Holdings <9143> 1,485 -44.5. Break of lower support line leads to increased selling pressure. Tokai Tokyo Financial Holdings <8616> 589 -14. Small and medium-sized securities.
Active and newly listed stocks during the morning session.
*Migalo HD<5535> 4405 +555 continues to view the introduction of "FreeiD" as material. *Money Forward<3994> 5195 +336 continues to recommend buying at Merrill Lynch Japan Securities. *Ain HD<9627> 5982 +363 Even though a reduction in profit guidance for this quarter has been announced, the sense of superiority remains. *Laser Tech<6920> 36690 +2170 Publicly disclosing the order status of the ATCIS series and other concerns have been dispelled. *Trichemical Research Institute<43>
Fanpep and other stocks with potential based on volume changes.
Stock Closing price Previous day change Volume * <4881> Fanpep 163 7 3438800 * <4438> Welby 630 100 370200 * <3544> Satsudra HD 902 41 342200 * <7134> Upgarage G 1026 106 120600 * <4196> Neomarke 996 6 40800 * <5596> Au
Stocks that moved the previous day part 1: Karada Note, Osaka Soda, Tokyo Electron Ltd. unsponsored ADR, etc.
Stock name <Code> June 6th closing price⇒compared to the previous day, Sakura <3778> 5110 +115 announced that it will raise about 18.8 billion yen with the new share issuance. The funds raised will be used to establish new datacenters, and thus growth expectations are increasing. JINSHD <3046> 3760 +555 same-store sales of national eyewear shops increased by 13.7% in May, expanding from 5.5% in April. Sumitomo Housing <1928> 3670 +148 revised upward its fiscal year 2025 performance and dividend estimates. Karada-noo, etc.
Active and newly established stocks in the afternoon session.
*Sakura <3778>: announced that it will raise about 18.8 billion yen by issuing new shares, and the raised funds will be used for the establishment of datacenters and other facilities, etc., which will increase growth expectations. *JINSHD <3046>: Same-store sales of domestic eyewear shops in May increased by 13.7% from April's 5.5% increase, with a expanding growth rate. *Sumitomo House <1928>: Revised its performance and dividend estimates for the fiscal year ending January 2025 upward. *Karada Note <4014>: 640.
Fanpep has signed an exclusive licensing agreement for the antibody-induced peptide FPP004X.
On the 5th, Fanpep <4881> announced that it has signed a contract with Osaka University regarding the co-owned patent of antibody-inducing peptide FPP004X, which enables the company to exclusively conduct research, development, manufacture, and sales worldwide as well as grant third-party licenses based on the validity of the patent rights.
Steady support from high US stocks and low long-term US interest rates.
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to perform well. In the US stock market on the 5th, the Dow Jones Industrial Average continued to rise, closing at a high of 38,807.33 (+0.25%) up 96.04 dollars from the previous day. With the lower-than-expected growth in private sector ADP employment statistics spreading expectations of early rate cuts, it became a support for stock prices. The Nasdaq continued to rise, boosted by the consecutive rise of semiconductor stock Nvidia, and remained strong throughout the day, closing at an all-time high. Today's emerging market is dominated by buying.
The era of 5 million dementia patients has arrived, promising stocks and overall verification of social issues. <Stock Top Feature>
The second meeting of the conference for promoting dementia policies was held on May 8th, and it was estimated that the number of dementia patients would reach 5.231 million in 2030 (4.432 million in 2022). The "Basic Law on Dementia" was enacted in January of this year to realize a society in which people with dementia can live together, and discussions are underway to formulate a basic plan. However, to overcome the era of 5 million dementia patients, it is essential to utilize both policies and treatments, as well as technology. Therefore, this time, we focus on related stocks that confront social issues.
Check the disclosed information for "Tomorrow's Positive and Negative Materials"! (Announced on June 5th)
Good Materials: ---------------- - Lear (Tokyo Stock Exchange: G) submitted a report on a large shareholding on the 5th. The shareholding ratio of Lear's stock in Optical Communications Co., Ltd. has reached 5.10%, and it has been revealed that it has exceeded 5% for the first time. - Ootoya Holdings Co., Ltd. (Tokyo Stock Exchange: S) has continued to increase its sales in May, with a same-store sales growth of 11.1% compared to the same period last year. - Seria Co., Ltd. (Tokyo Stock Exchange: S) had a same-store sales growth of 5.0% in May compared to the same period last year. - JINS Holding Co., Ltd.
Property data banks, Lifenet Life Insurance, etc.
＜4389＞Property Data Bank Co., Ltd. Hikari Communication Co., Ltd. Stock Ownership Ratio -% → 5.06% Reporting Obligation Date 2024/05/16 ＜4564＞OncoTherapy Science Co., Ltd. Long Corridor Asset Management Limited (Long Corridor Asset Management Limited) Stock Ownership Ratio 17.67% → 16.20% Reporting Obligation Date 2024/0
Digital Plus, Genext, etc.
＜3133＞Kaiho Co., Ltd. Yamada Toru Stock Ownership Ratio 12.99% → 14.18% Reporting Obligation Date 2024/04/26 ＜3237＞Intrans Co., Ltd. Intrans LLC Inbound Investment Stock Ownership Ratio 43.50% → 31.27% Reporting Obligation Date 2024/05/08 ＜3491＞GA Technology Co., Ltd. Ryu Higuchi Stock Holding Ratio 43.17% → 42.35% Report
Analysis
Price Target
No Data
